203 related articles for article (PubMed ID: 35389052)
1. Liver imaging: it is time to adopt standardized terminology.
Chernyak V; Tang A; Do RKG; Kamaya A; Kono Y; Santillan CS; Fowler KJ; Bashir MR; Cunha GM; Fetzer DT; Kielar A; Lee JT; Mendiratta-Lalla M; Sirlin CB;
Eur Radiol; 2022 Sep; 32(9):6291-6301. PubMed ID: 35389052
[TBL] [Abstract][Full Text] [Related]
2. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
3. Implementation of LI-RADS into a radiological practice.
Siedlikowski ST; Kielar AZ; Ormsby EL; Bijan B; Kagay C
Abdom Radiol (NY); 2018 Jan; 43(1):179-184. PubMed ID: 28634619
[TBL] [Abstract][Full Text] [Related]
4. Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma.
Tang A; Singal AG; Mitchell DG; Hecht EM; Fowler KJ; Kulik L; Parikh ND; Kono Y; Sirlin CB
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1228-1238. PubMed ID: 30326302
[TBL] [Abstract][Full Text] [Related]
5. LI-RADS
Chernyak V; Santillan CS; Papadatos D; Sirlin CB
Abdom Radiol (NY); 2018 Jan; 43(1):111-126. PubMed ID: 28695233
[TBL] [Abstract][Full Text] [Related]
6. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
7. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know.
Tang A; Valasek MA; Sirlin CB
Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514
[TBL] [Abstract][Full Text] [Related]
8. LI-RADS categories: concepts, definitions, and criteria.
Santillan C; Chernyak V; Sirlin C
Abdom Radiol (NY); 2018 Jan; 43(1):101-110. PubMed ID: 29038857
[TBL] [Abstract][Full Text] [Related]
9. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
[TBL] [Abstract][Full Text] [Related]
10. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
Tang A; Bashir MR; Corwin MT; Cruite I; Dietrich CF; Do RKG; Ehman EC; Fowler KJ; Hussain HK; Jha RC; Karam AR; Mamidipalli A; Marks RM; Mitchell DG; Morgan TA; Ohliger MA; Shah A; Vu KN; Sirlin CB;
Radiology; 2018 Jan; 286(1):29-48. PubMed ID: 29166245
[TBL] [Abstract][Full Text] [Related]
11. Understanding LI-RADS: a primer for practical use.
Santillan CS; Tang A; Cruite I; Shah A; Sirlin CB
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):337-52. PubMed ID: 25086933
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
Kim TK; Noh SY; Wilson SR; Kono Y; Piscaglia F; Jang HJ; Lyshchik A; Dietrich CF; Willmann JK; Vezeridis A; Sirlin CB
Clin Mol Hepatol; 2017 Dec; 23(4):280-289. PubMed ID: 28911220
[TBL] [Abstract][Full Text] [Related]
13. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI.
Wilson SR; Lyshchik A; Piscaglia F; Cosgrove D; Jang HJ; Sirlin C; Dietrich CF; Kim TK; Willmann JK; Kono Y
Abdom Radiol (NY); 2018 Jan; 43(1):127-142. PubMed ID: 28819825
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
15. Imaging diagnosis of hepatocellular carcinoma: LI-RADS.
Cunha GM; Sirlin CB; Fowler KJ
Chin Clin Oncol; 2021 Feb; 10(1):3. PubMed ID: 32527115
[TBL] [Abstract][Full Text] [Related]
16. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.
Santillan C; Fowler K; Kono Y; Chernyak V
Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
[TBL] [Abstract][Full Text] [Related]
18. Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.
Fraum TJ; Cannella R; Ludwig DR; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
Eur Radiol; 2020 Feb; 30(2):996-1007. PubMed ID: 31654212
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
[TBL] [Abstract][Full Text] [Related]
20. [Contrast-enhanced ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS)].
Dietrich CF; Potthoff A; Helmberger T; Ignee A; Willmann JK;
Z Gastroenterol; 2018 May; 56(5):499-506. PubMed ID: 29734449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]